Once-Monthly Ibandronate for Osteoporosis

Roche and GlaxoSmithKline have announced the FDA’s approval of a once-monthly oral bisphosphonate, ibandronate sodium (Boniva®) 150-mg tablets, for patients with postmenopausal osteoporosis.
canadian cialis online

This is the first oral therapy administered as one tablet once a month for any chronic disease. Patients will be able to take 12 tablets per year, not 52, as with traditional weekly bisphosphonate treatments.